查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447130

到 2030 年 L-麥角硫因市場預測：按類型、原料、型態、分銷管道、應用和地區進行的全球分析

L-ergothioneine Market Forecasts to 2030 - Global Analysis By Type (Fermentation-based Production, Chemical Synthesis and Biosynthesis), By Source (Mushrooms, Algae and Bacteria), Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年 L-麥角硫因的全球市場規模為 3,950 萬美元，預計在預測期內將以 34.4% 的年複合成長率成長，並在 2030 年達到 3.128 億美元。

L-麥角硫因是一種天然存在的胺基酸衍生物，具有強烈的抗氧化特性。它由某些真菌和細菌合成，在各種食品中含有微量。 L-麥角硫因可作為有害自由基的清除劑，保護細胞免受氧化損傷，並可能具有發炎和抗衰老等健康益處。

據美國國家癌症美國稱，蘑菇的抗氧化特性可能有助於降低乳癌、攝護腺癌和肺癌的風險。

慢性病增加

慢性病的增加是 L-麥角硫因市場的促進因素。慢性疾病的特徵是氧化壓力和發炎，導致組織損傷和功能障礙。 L-麥角硫因具有很強的抗氧化和發炎特性，已顯示出減輕氧化損傷和發炎的潛力，從而為慢性病的預防和管理提供治療益處。這增加了對 L-麥角硫因作為營養補充和藥物配方中的功能成分的需求。

生產成本高

涉及發酵和化學合成的複雜且專業的製造流程需要精密的設備和熟練的勞動力，導致製造成本不斷上升。此外，L-麥角硫因的天然來源有限，進一步加劇了生產成本。這些高成本導致 L-麥角硫因產品價格高昂，並可能阻礙市場成長和普及。

合成L-麥角硫因的開發

與天然來源萃取相比，合成生產方法具有成本效益、擴充性和品管等優點。這可以滿足藥品、化妝品、營養補充等各行業對L-麥角硫因日益成長的需求。此外，合成生產允許客製化和配方彈性，允許創建新的應用並增加 L-麥角硫因在市場上的可用性。

存在仿冒品和劣質 L-麥角硫因產品

仿冒品和劣質 L-麥角硫因產品的存在對市場構成威脅。這些產品可能缺乏功效、純度和安全性，並對消費者構成潛在的健康風險。此外，它還削弱了消費者對 L-麥角硫因和整個產業的信心。此類產品的氾濫也損害了合法製造商和分銷商的聲譽，阻礙了市場成長。

COVID-19 的影響：

COVID-19 大流行對 L-麥角硫因市場產生了重大影響。在大流行期間，人們對健康和免疫力的興趣增加，導致人們對 L-麥角硫因等抗氧化劑的興趣增加。然而，供應鏈和製造業務的中斷影響了生產和分銷，導致供應和價格波動。儘管面臨挑戰，疫情凸顯了 L-麥角硫因的潛在健康益處，並推動了對該成分的需求。

預計粉末細分市場在預測期內將是最大的

在L-麥角硫因市場中，由於各種因素，預計粉末部分在預測期內將成為最大的部分。粉狀 L-麥角硫因具有多種配方和用途，可用於多種行業，包括藥品、化妝品和食品。此外，製造商更喜歡粉末狀，因為它們更容易處理、儲存和摻入配方中。此外，粉末狀L-麥角硫因可以輕鬆標準化並配製成各種產品，使其在市場上具有競爭優勢。

預計製藥業在預測期內年複合成長率最高

在L-麥角硫因市場中，製藥領域預計在預測期內將呈現最高成長率。這一成長歸因於專注於探索 L-麥角硫因在治療各種疾病方面的治療潛力的研發活動的增加。此外，慢性病和與老齡化相關的疾病盛行率不斷上升，刺激了對含有 L-麥角硫因的創新藥物配方的需求，從而推動了製藥業的成長。

比最大的地區

由於其發達的醫療保健基礎設施、消費者對健康和保健的意識不斷增強以及製藥和化妝品行業的主要企業的存在，預計北美將主導 L-麥角硫因市場。此外，積極的研發活動，加上對含有L-麥角硫因的營養補充和護膚品的需求不斷成長，使得北美在L-麥角硫因市場上佔據了最大的市場佔有率。

年複合成長率最高的地區：

由於人口成長、可支配收入增加以及人們對健康和保健意識的提高，預計亞太地區 L-麥角硫因市場將快速成長。此外，中國、日本和印度等國家的製藥、化妝品和營養補充產業不斷擴大，為L-麥角硫因製造商創造了龐大的商機。此外，支持研發活動的有利政府舉措進一步促進了該地區市場的快速成長潛力。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球 L-麥角硫因市場：依類型

  • 發酵生產
  • 化學合成
  • 生物合成

第6章全球 L-麥角硫因市場：依原料分類

  • 菇
    • 藥用菇
    • 食用菌
  • 藻類
  • 細菌

第7章全球 L-麥角硫因市場：依型態

  • 粉末
  • 液體
  • 膠囊
  • 其他型態

第8章全球 L-麥角硫因市場：按分銷管道

  • 直銷
  • 代理銷售
  • 網路零售
  • 專賣店

第9章全球 L-麥角硫因市場：依應用分類

  • 藥品
  • 個人護理和化妝品
  • 食品與飲品
  • 其他用途

第10章全球 L-麥角硫因市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Alfa Aesar
  • BOC Sciences
  • Cayman Chemical
  • ChemFaces
  • Chemieliva Pharmaceutical Co., Ltd.
  • Chemwill Asia Co., Ltd.
  • Evonik Industries AG
  • Gea Group AG
  • Gold Biotechnology, Inc.
  • Hangzhou J&H Chemical Co., Ltd.
  • Hangzhou Lingrui Chemical Co., Ltd.
  • Hefei TNJ Chemical Industry Co., Ltd.
  • Henan Tianfu Chemical Co., Ltd.
  • Kanto Chemical Co., Inc.
  • Merck KGaA
  • Santa Cruz Biotechnology, Inc.
  • Shanghai Haoyuan Chemexpress Co., Ltd.
  • Suzhou Health Chemicals Co., Ltd.
  • Zhonglan Industry Co., Ltd.
Product Code: SMRC25391

According to Stratistics MRC, the Global L-ergothioneine Market is accounted for $39.5 million in 2023 and is expected to reach $312.8 million by 2030 growing at a CAGR of 34.4% during the forecast period. L-ergothioneine is a naturally occurring amino acid derivative with potent antioxidant properties. It is synthesized by certain fungi and bacteria and is found in trace amounts in various foods. L-ergothioneine acts as a scavenger of harmful free radicals, protecting cells from oxidative damage and potentially offering health benefits, including anti-inflammatory and anti-aging effects.

According to the National Cancer Institute, the antioxidant property of mushrooms may help to reduce the risk of breast, prostate, lung, and other cancers.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases serves as a driver in the L-ergothioneine market. Chronic diseases are characterized by oxidative stress and inflammation, leading to tissue damage and dysfunction. L-ergothioneine, with its potent antioxidant and anti-inflammatory properties, has shown potential for mitigating oxidative damage and inflammation, thereby offering therapeutic benefits in the prevention and management of chronic diseases. This drives the demand for L-ergothioneine as a functional ingredient in dietary supplements and pharmaceutical formulations.

Restraint:

High production costs

The complex and specialized production process, which involves fermentation or chemical synthesis, requires sophisticated equipment and skilled labor, contributing to elevated manufacturing expenses. Additionally, the limited natural sources of L-ergothioneine further exacerbate production costs. These high expenses may result in higher prices for L-ergothioneine products, potentially hindering market growth and adoption.

Opportunity:

Development of synthetic L-ergothioneine

Synthetic production methods can offer advantages such as cost-effectiveness, scalability, and quality control compared to extraction from natural sources. This can meet the increasing demand for L-ergothioneine in various industries, including pharmaceuticals, cosmetics, and dietary supplements. Moreover, synthetic production allows for customization and formulation flexibility, enabling the creation of new applications and enhancing the accessibility of L-ergothioneine on the market.

Threat:

Presence of counterfeit or low-quality L-ergothioneine products

The presence of counterfeit or low-quality L-ergothioneine products poses a threat to the market. These products may lack efficacy, purity, and safety, leading to potential health risks for consumers. Furthermore, they undermine consumer trust in L-ergothioneine and the industry as a whole. The proliferation of such products can also tarnish the reputation of legitimate manufacturers and distributors, which hinders market growth.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the L-ergothioneine market. The increased focus on health and immunity during the pandemic led to a growing interest in antioxidants like L-ergothioneine. However, disruptions in supply chains and manufacturing operations affected production and distribution, resulting in fluctuating availability and pricing. Despite the challenges, the pandemic highlighted the potential health benefits of L-ergothioneine, driving demand for the ingredient.

The powder segment is expected to be the largest during the forecast period

The powder segment is anticipated to be the largest during the forecast period in the L-ergothioneine market due to various factors. Powdered L-ergothioneine offers versatility in formulation and application across various industries, including pharmaceuticals, cosmetics, and dietary supplements. Additionally, powdered form facilitates easy handling, storage, and blending into formulations, making it preferred by manufacturers. Moreover, powdered L-ergothioneine can be easily standardized and formulated into different products, driving its dominance in the market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

The pharmaceuticals segment is projected to experience the highest growth rate during the forecast period in the L-ergothioneine market. This growth can be attributed to the increasing research and development activities focused on exploring the therapeutic potential of L-ergothioneine in treating various medical conditions. Additionally, the rising prevalence of chronic diseases and age-related disorders has fueled demand for innovative pharmaceutical formulations containing L-ergothioneine, driving its growth in the pharmaceuticals segment.

Region with largest share:

North America is expected to dominate the L-ergothioneine market due to the region's advanced healthcare infrastructure, increasing consumer awareness about health and wellness, and the presence of key players in the pharmaceutical and cosmetic industries. Additionally, robust research and development activities, coupled with a growing demand for dietary supplements and skincare products containing L-ergothioneine, further contribute to North America's anticipated largest market share in the L-ergothioneine market.

Region with highest CAGR:

The Asia-Pacific region is poised for rapid growth in the L-ergothioneine market due to the region's increasing population, rising disposable incomes, and growing awareness of health and wellness. Additionally, the expanding pharmaceutical, cosmetic, and dietary supplement industries in countries like China, Japan, and India present significant opportunities for L-ergothioneine manufacturers. Moreover, favorable government initiatives supporting research and development activities further contribute to the region's potential for rapid market growth.

Key players in the market

Some of the key players in L-ergothioneine market include Alfa Aesar, BOC Sciences, Cayman Chemical, ChemFaces, Chemieliva Pharmaceutical Co., Ltd., Chemwill Asia Co., Ltd., Evonik Industries AG, Gea Group AG, Gold Biotechnology, Inc., Hangzhou J&H Chemical Co., Ltd., Hangzhou Lingrui Chemical Co., Ltd., Hefei TNJ Chemical Industry Co., Ltd., Henan Tianfu Chemical Co., Ltd., Kanto Chemical Co., Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Shanghai Haoyuan Chemexpress Co., Ltd., Suzhou Health Chemicals Co., Ltd. and Zhonglan Industry Co., Ltd.

Key Developments:

In June 2022, BOC Sciences, a leading CRO in the pharmaceutical industry, demonstrates its comprehensive strength through innovative lysosome-targeting chimera (LYTAC) degradation technology solutions developed within the field of targeted protein degradation. LYTAC is a new technology that can degrade extracellular proteins and membrane-related proteins through the endosomal/lysosomal pathway.

In October 2021, Thermo Fisher Scientific recently announced consolidation of its product portfolio brands Acros Organics, Alfa Aesar and Maybridge transitioning to one unified brand, Thermo Scientific. This transition is a response to the customer's feedback to simplify the buying journey experience. The transition will be effective from mid- October 2021 and all products of Alfa Aesar(TM), Acros, Organics(TM) and Maybridge(TM) packed and labeled from mid-October 2021 onwards will be branded as Thermo Scientific(TM).

Types Covered:

  • Fermentation-based Production
  • Chemical Synthesis
  • Biosynthesis

Sources Covered:

  • Mushrooms
  • Algae
  • Bacteria

Forms Covered:

  • Powder
  • Liquid
  • Capsule
  • Other Forms

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Retail
  • Specialty Stores

Applications Covered:

  • Pharmaceuticals
  • Personal Care & Cosmetics
  • Food & Beverages
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global L-ergothioneine Market, By Type

  • 5.1 Introduction
  • 5.2 Fermentation-based Production
  • 5.3 Chemical Synthesis
  • 5.4 Biosynthesis

6 Global L-ergothioneine Market, By Source

  • 6.1 Introduction
  • 6.2 Mushrooms
    • 6.2.1 Medicinal Mushrooms
    • 6.2.2 Edible Mushrooms
  • 6.3 Algae
  • 6.4 Bacteria

7 Global L-ergothioneine Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsule
  • 7.5 Other Forms

8 Global L-ergothioneine Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors
  • 8.4 Online Retail
  • 8.5 Specialty Stores

9 Global L-ergothioneine Market, By Application

  • 9.1 Introduction
  • 9.2 Pharmaceuticals
  • 9.3 Personal Care & Cosmetics
  • 9.4 Food & Beverages
  • 9.5 Other Applications

10 Global L-ergothioneine Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Alfa Aesar
  • 12.2 BOC Sciences
  • 12.3 Cayman Chemical
  • 12.4 ChemFaces
  • 12.5 Chemieliva Pharmaceutical Co., Ltd.
  • 12.6 Chemwill Asia Co., Ltd.
  • 12.7 Evonik Industries AG
  • 12.8 Gea Group AG
  • 12.9 Gold Biotechnology, Inc.
  • 12.10 Hangzhou J&H Chemical Co., Ltd.
  • 12.11 Hangzhou Lingrui Chemical Co., Ltd.
  • 12.12 Hefei TNJ Chemical Industry Co., Ltd.
  • 12.13 Henan Tianfu Chemical Co., Ltd.
  • 12.14 Kanto Chemical Co., Inc.
  • 12.15 Merck KGaA
  • 12.16 Santa Cruz Biotechnology, Inc.
  • 12.17 Shanghai Haoyuan Chemexpress Co., Ltd.
  • 12.18 Suzhou Health Chemicals Co., Ltd.
  • 12.19 Zhonglan Industry Co., Ltd.

List of Tables

  • Table 1 Global L-ergothioneine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global L-ergothioneine Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global L-ergothioneine Market Outlook, By Fermentation-based Production (2021-2030) ($MN)
  • Table 4 Global L-ergothioneine Market Outlook, By Chemical Synthesis (2021-2030) ($MN)
  • Table 5 Global L-ergothioneine Market Outlook, By Biosynthesis (2021-2030) ($MN)
  • Table 6 Global L-ergothioneine Market Outlook, By Source (2021-2030) ($MN)
  • Table 7 Global L-ergothioneine Market Outlook, By Mushrooms (2021-2030) ($MN)
  • Table 8 Global L-ergothioneine Market Outlook, By Medicinal Mushrooms (2021-2030) ($MN)
  • Table 9 Global L-ergothioneine Market Outlook, By Edible Mushrooms (2021-2030) ($MN)
  • Table 10 Global L-ergothioneine Market Outlook, By Algae (2021-2030) ($MN)
  • Table 11 Global L-ergothioneine Market Outlook, By Bacteria (2021-2030) ($MN)
  • Table 12 Global L-ergothioneine Market Outlook, By Form (2021-2030) ($MN)
  • Table 13 Global L-ergothioneine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 14 Global L-ergothioneine Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 15 Global L-ergothioneine Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 16 Global L-ergothioneine Market Outlook, By Other Forms (2021-2030) ($MN)
  • Table 17 Global L-ergothioneine Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 18 Global L-ergothioneine Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 19 Global L-ergothioneine Market Outlook, By Distributors (2021-2030) ($MN)
  • Table 20 Global L-ergothioneine Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 21 Global L-ergothioneine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 22 Global L-ergothioneine Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global L-ergothioneine Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 24 Global L-ergothioneine Market Outlook, By Personal Care & Cosmetics (2021-2030) ($MN)
  • Table 25 Global L-ergothioneine Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 26 Global L-ergothioneine Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.